From sequence to scaffold: Computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks
Abstract
Self-assembling protein nanoparticles are being increasingly utilized in the design of next-generation vaccines due to their ability to induce antibody responses of superior magnitude, breadth, and durability. Computational protein design offers a route to nanoparticle scaffolds with structural and biochemical features tailored to specific vaccine applications. Although strategies for designing self-assembling proteins have been established, the recent development of powerful machine learning (ML)–based tools for protein structure prediction and design provides an opportunity to overcome several of their limitations. Here, we leveraged these tools to develop a generalizable method for designing self-assembling proteins starting from AlphaFold2 predictions of oligomeric protein building blocks. We used the method to generate six 60-subunit protein nanoparticles with icosahedral symmetry, and single-particle cryoelectron microscopy reconstructions of three of them revealed that they were designed with atomic-level accuracy. To transform one of these nanoparticles into a functional immunogen, we reoriented its termini through circular permutation, added a genetically encoded oligomannose-type glycan, and displayed a stabilized trimeric variant of the influenza hemagglutinin receptor-binding domain through a rigid de novo linker. The resultant immunogen elicited potent receptor-blocking and neutralizing antibody responses in mice. Our results demonstrate the practical utility of ML–based protein modeling tools in the design of nanoparticle vaccines. More broadly, by eliminating the requirement for experimentally determined structures of protein building blocks, our method dramatically expands the number of starting points available for designing self-assembling proteins.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (11)
Cyrus M. Haas
Department of Chemical Engineering, University of Washington
Naveen Jasti
Institute for Protein Design, University of Washington
Annie Dosey
Institute for Protein Design, University of Washington
Joel D. Allen
School of Biological Sciences, University of Southampton, Southampton, UK.
Rebecca Gillespie
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH
Jackson McGowan
Institute for Protein Design, University of Washington
Elizabeth M. Leaf
Max Crispin
School of Biological Sciences, University of Southampton, Southampton, UK.
Cole A. DeForest
Department of Chemical Engineering, University of Washington
Masaru Kanekiyo
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH
Neil P. King